SCHEMBL5097122

SCHEMBL5097122

CN1CCOc2cc(S(=O)(=O)n3ncc4ccc(N5CCCNCC5)cc43)ccc21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 1/20 0.39
ALDH1A1 P00352 1/20 0.38
HTT P42858 1/20 0.38
RECQL P46063 1/20 0.38
HTR6 P50406 4/20 0.38
GBA1 P04062 1/20 0.38
NOTUM Q6P988 1/20 0.38
L3MBTL1 Q9Y468 2/20 0.36
PTGES2 Q9H7Z7 1/20 0.36
USP9X Q93008 2/20 0.36
HCRTR1 O43613 1/20 0.36
HCRTR2 O43614 1/20 0.36
DRD3 P35462 1/20 0.36
POLB P06746 1/20 0.35
HDAC3 O15379 1/20 0.35
HDAC4 P56524 1/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC7 Q8WUI4 1/20 0.35
HDAC2 Q92769 1/20 0.35
HDAC10 Q969S8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5103449 0.97 GHSR (0.41) GHSRALDH1A1HTTRECQLHTR6
SCHEMBL5091052 0.90 PKM (0.43) HTR6L3MBTL1USP9XDRD3RIPK2
SCHEMBL5097156 0.88 PKM (0.42) GHSRALDH1A1HTTRECQLHTR6
SCHEMBL5103502 0.88 GBA1 (0.44) GHSRALDH1A1HTTRECQLHTR6
SCHEMBL5103748 0.84 HTR6 (0.48) GHSRALDH1A1HTTRECQLHTR6
SCHEMBL5097570 0.84 USP9X (0.48) ALDH1A1HTTHTR6L3MBTL1USP9X
SCHEMBL5097431 0.83 HTR6 (0.40) HTR6USP9XDRD3RIPK2NOD2
SCHEMBL5097211 0.81 HTR6 (0.50) GHSRALDH1A1HTTRECQLHTR6
SCHEMBL5095027 0.80 KHK (0.45) GHSRALDH1A1HTTRECQLHTR6
SCHEMBL5097203 0.79 HTR6 (0.40) ALDH1A1HTR6USP9X

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080200471-A1 6' SUBSTITUTED COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY MEMORY PHARMACEUTICALS CORPORATION (US) 2008-08-21 US claimed
US-20080200471-A1 6' SUBSTITUTED COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY MEMORY PHARMACEUTICALS CORPORATION (US) 2008-08-21 US disclosed
US-20080200471-A1 6' SUBSTITUTED COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY MEMORY PHARMACEUTICALS CORPORATION (US) 2008-08-21 US disclosed
US-20080200471-A1 6' SUBSTITUTED COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY MEMORY PHARMACEUTICALS CORPORATION (US) 2008-08-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080200471-A1 6' SUBSTITUTED COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY HTR6, HTR1B, HTR1A GHSR 192/4885ALDH1A1 881/4885HTT 1740/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.